Awidi M, Mier-Hicks A, Perimbeti S, Attwood K, et al. Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients? Clin Lung Cancer 2024 May 29:S1525-7304(24)00082.
PMID: 38879394